Omalizumab for treatment of ABPA exacerbations in CF patients

Pediatr Pulmonol. 2009 May;44(5):516. doi: 10.1002/ppul.21002.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adolescent
  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Aspergillosis, Allergic Bronchopulmonary / complications*
  • Aspergillosis, Allergic Bronchopulmonary / drug therapy*
  • Cystic Fibrosis / complications*
  • Humans
  • Omalizumab

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab